Treatment Considerations for Older Patients with Acute Myeloid Leukemia
There is a need for improved therapeutic strategies to manage AML disease progression, especially in older adults.
Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with AML.
Exploring an Expanding AML Therapeutic Armamentarium: Expert Guidance to Optimize Outcomes
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with AML.
Archived Monthly Oncology Tumor Boards: Advances in Multidisciplinary Management of Acute Myeloid Leukemia
Clinicians need to be informed about therapeutic advances and necessary supportive care precautions to aid in their effective and safe incorporation into clinical practice for the appropriate AML patient subpopulations.
Exploring an Expanding AML Therapeutic Armamentarium: Expert Guidance to Optimize Outcomes
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with AML.
Treatment Updates in Acute Myeloid Leukemia
Informing clinicians about therapeutic advances and necessary supportive care precautions will aid in their efficacious and safe incorporation into clinical practice for the appropriate AML patient subpopulations.
Monthly Oncology Tumor Boards: Advances in Multidisciplinary Management of Acute Myeloid Leukemia
Clinicians need to be informed about therapeutic advances and necessary supportive care precautions to aid in their effective and safe incorporation into clinical practice for the appropriate AML patient subpopulations.
NCCN Guidelines® Insights - Acute Myeloid Leukemia, Version 2.2021
These NCCN Guidelines Insights focus on recent select updates to the NCCN Guidelines, including familial genetic alterations in AML, postinduction or postremission treatment strategies in low-risk acute promyelocytic leukemia or favorable-risk AML, principles surrounding the use of venetoclax-based therapies, and considerations for patients who prefer not to receive blood transfusions during treatment.
AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm

The goal of this activity is to improve the competence and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with AML.

 

AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm

The goal of this activity is to improve the competence and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with AML.

 

Pages

Subscribe to RSS - Acute Myelogenous Leukemia